This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: **Innovative Contributions of Leo Chan in Drug Delivery Technology**
Introduction
Leo Chan, an inventive mind based in Fremont, California, has made significant strides in the field of pharmaceutical technology. With a focus on refining drug delivery systems, he holds a patent that showcases his ability to innovate in medical devices. His work at Novartis AG reflects his commitment to advancing healthcare solutions.
Latest Patents
Leo Chan's notable patent is for an “Aerosolization apparatus for inhalation profile-independent drug delivery.” This invention features a unique powder aerosolization apparatus equipped with a housing that includes an outlet for user interaction and multiple bypass air openings. This design supports efficient aerosolization of powder pharmaceutical formulations, creating a reliable method for inhalation therapies. The apparatus is designed to only deliver aerosolized medication at a predetermined inhalation flow rate, which optimizes patient experience and therapeutic effectiveness.
Career Highlights
Throughout his career, Leo Chan has been an instrumental figure in the development of innovative drug delivery technologies. His patent stands as a testament to his expertise and forward-thinking approach. As an inventor at Novartis AG, he contributes to one of the leading pharmaceutical companies that prioritize cutting-edge solutions in medicine.
Collaborations
Leo has worked alongside talented professionals in the industry, including coworkers Keith Ung and Jeffry Weers. Through their collaborative efforts, they continue to push the boundaries of what is possible in pharmaceutical innovation, enhancing the potential for improved health outcomes for patients around the world.
Conclusion
In conclusion, Leo Chan's contributions to drug delivery technology mark him as a distinguished inventor. His patented aerosolization apparatus demonstrates not only innovation but also a deep understanding of patient needs in inhalation therapies. Through his work at Novartis AG and collaborations with colleagues, Chan is set to make lasting impacts in the healthcare industry, paving the way for future advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile